News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Gravitz joins PCI from the Advanced Research Projects Agency for Health (ARPA‑H).
In this role, he aims to advance innovation in cancer treatment and prevention.
This approach may pave the way for potentially safer, more accessible, and cost-effective treatments for solid tumors.
Mitchell and his team discovered that lipid nanoparticles (LNPs) can be used to modify the metabolism of immune cells.
Researchers leveraged topological design principles to develop stable chip networks that guide multiple light signals at once.
The visit included meetings with researchers, clinicians, and innovators at Penn and a tour of one of Penn’s CAR T cell laboratories.
The report highlighted several Penn spinouts.
TerraPower will establish a 250,000 square foot manufacturing facility in Philadelphia’s Bellwether District.
The fund will finance innovative projects at their earliest stages.
He discussed Penn's role in and impact on the greater community.